Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.

[This corrects the article DOI: 10.1371/journal.pone.0034805.].

Bibliographic Details
Main Authors:	Anna Bobrowska, Gizem Donmez, Andreas Weiss, Leonard Guarente, Gillian Bates
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0248926

id	doaj-45ad3dad1c9e4a9d8a306d128b8e5948
record_format	Article
spelling	doaj-45ad3dad1c9e4a9d8a306d128b8e59482021-04-08T04:30:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01163e024892610.1371/journal.pone.0248926Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.Anna BobrowskaGizem DonmezAndreas WeissLeonard GuarenteGillian Bates[This corrects the article DOI: 10.1371/journal.pone.0034805.].https://doi.org/10.1371/journal.pone.0248926
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Anna Bobrowska Gizem Donmez Andreas Weiss Leonard Guarente Gillian Bates
spellingShingle	Anna Bobrowska Gizem Donmez Andreas Weiss Leonard Guarente Gillian Bates Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. PLoS ONE
author_facet	Anna Bobrowska Gizem Donmez Andreas Weiss Leonard Guarente Gillian Bates
author_sort	Anna Bobrowska
title	Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.
title_short	Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.
title_full	Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.
title_fullStr	Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.
title_full_unstemmed	Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.
title_sort	correction: sirt2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of huntington's disease phenotypes in vivo.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2021-01-01
description	[This corrects the article DOI: 10.1371/journal.pone.0034805.].
url	https://doi.org/10.1371/journal.pone.0248926
work_keys_str_mv	AT annabobrowska correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT gizemdonmez correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT andreasweiss correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT leonardguarente correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT gillianbates correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo
_version_	1714688205745291264

Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.

Similar Items